Myriad Genetics |
日期/時間 | / |
漲跌。 / 漲跌。(%) | - / |
Bid | - |
Ask | - |
打開 | - |
過往收市 | - |
高 | - |
低 | - |
成交量 [USD] | - |
成交量 [Units] | |
Price fixings | |
ISIN | US62855J1043 |
符號 | MYGN |
交易所 | IEX |
類型 | 股票 |
所有交易
交易所 | 最後的 | 成交量 | |
---|---|---|---|
NASDAQ | 21,9700 | ![]() |
427.970 |
IEX | 21,99 | ![]() |
19.031 |
Cboe US | 21,98 | ![]() |
14.585 |
TradeGate | 20,320 | ![]() |
56 |
Xetra | 20,210 | ![]() |
0 |
Hannover | 20,380 | ![]() |
0 |
Frankfurt | 20,3700 | ![]() |
0 |
Berlin | 20,400 | ![]() |
0 |
München | 20,380 | ![]() |
0 |
Hamburg | 20,380 | ![]() |
0 |
Düsseldorf | 20,210 | ![]() |
0 |
Stuttgart | 20,480 | ![]() |
0 |
Lang & Schwa.. | 20,570 | ![]() |
|
gettex | 20,780 | ![]() |
|
Quotrix | 20,4700 | ![]() |
|
London Domes.. | 22,06 | 100 |
新聞
- Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care
14.03.2022 / 12:05 - GlobeNewswire - Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
12.03.2022 / 01:05 - GlobeNewswire - Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
08.03.2022 / 13:22 - GlobeNewswire - Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference
02.03.2022 / 22:30 - GlobeNewswire - Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
24.02.2022 / 15:00 - GlobeNewswire
Personal area
Click on
to activate push quotes.
